QNRX

Quoin Pharmaceuticals Ltd.

Healthcare · Biotechnology

$244.62 sample

-0.20 (-0.08%) 1D

Market cap

$757.6B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-05

Alerts

8

Price$244.62 -5.10% 3M daily closessample

261.49243.89

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider sell: Chief Executive Officer
Oct 08INSInsider sell: Chief Executive Officer
Oct 05SECForm 144 filed
Sep 24INSInsider sell: General Counsel
Sep 17SEC8-K filed: material event
Sep 10INSInsider sell: Chief Financial Officer
Sep 04SEC10-Q filed
Aug 26SEC8-K filed: material event

Sign up to see the real QNRX record →

Company facts

SEC EDGAR registration

Name: Quoin Pharmaceuticals Ltd.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +52sample, -100 to +100
Reporting currency: USD

Who is positioning in QNRX

sample

Insiders: 31 insider transactions over 90 days, net selling, $505.4M
Congress: 3 members traded over 90 days
Institutions · 13F: 31 funds hold $13.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$42.4B +18.3% y/y

Q4 2024Q3 2026

Inventory$24.0B +6.2% y/y

Q4 2024Q3 2026

Accounts receivable$17.8B +11.8% y/y

Q4 2024Q3 2026

Total debt$46.9B +3.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $644.6B +2.4% 3M
Sample peer B: $690.8B +11.0% 3M
Sample peer C: $465.6B +2.8% 3M
Sample peer D: $657.5B +6.1% 3M
Sample peer E: $633.8B -10.2% 3M